JETAL SHUKLA: Open Payments
NPI 1467854224 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 27 payments from 9 companies in 2025. Trend: 2023 $431 · 2024 $631 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $192 |
| Lilly USA, LLC | 3 | $58 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Amgen Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Wegovy, MOUNJARO, VRAYLAR, SHINGRIX, JARDIANCE, KRYSTEXXA, ZEPBOUND, Rybelsus.
Industry payments across NC — which companies pay providers there.
